Patents by Inventor R. Lawrence

R. Lawrence has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC CETP INHIBITORS
    Publication number: 20070161685
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Application
    Filed: November 15, 2006
    Publication date: July 12, 2007
    Inventors: Mark Salvati, Heather Finlay, Lalgudi Harikrishnan, Ji Jiang, James Johnson, Muthoni Kamau, R. Lawrence, Michael Miller, Jennifer Qiao, Tammy Wang, Yufeng Wang, Wu Yang
  • HETEROCYCLIC CETP INHIBITORS
    Publication number: 20070135631
    Abstract: Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.
    Type: Application
    Filed: November 13, 2006
    Publication date: June 14, 2007
    Inventors: Mark Salvati, Heather Finlay, Bang-Chi Chen, Lalgudi Harikrishnan, Ji Jiang, James Johnson, Muthoni Kamau, R. Lawrence, Jianqing Li, John Lloyd, Michael Miller, Zulan Pi, Jennifer Qiao, Richard Rampulla, Jacques Roberge, Tammy Wang, Yufeng Wang, Wu Yang
  • Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition
    Publication number: 20070004677
    Abstract: The present invention provides novel urea mimics and analogues of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, W, and R6 are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments.
    Type: Application
    Filed: June 26, 2006
    Publication date: January 4, 2007
    Applicant: Bristol-Myers Squibb Company
    Inventors: Hannguang Chao, R. Lawrence, Rejean Ruel, James Sutton
  • Anthranilic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
    Publication number: 20060135619
    Abstract: Anthranilic acid drivatives, methods of using such compounds in the treatment of hormone sensitive diseases such as prostate cancer, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: October 21, 2005
    Publication date: June 22, 2006
    Inventors: Ellen Kick, R. Lawrence, Brian Fink, Raj Misra, Gregory Vite
  • Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
    Publication number: 20060025403
    Abstract: Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates and prodrugs thereof, in which E is X is N or CH, W is —NR16R17, —NR16C(?O)R22, —NR16CO2R22, —OR23, or a heteroaryl or heterocyclo group as defined in the specification, and R1 through R12, R16, R17, R22, R23, x, y, and z are as defined in the specification, are useful as modulaters of melanocortin receptors, particularly MC-1R and MC-4R.
    Type: Application
    Filed: August 8, 2005
    Publication date: February 2, 2006
    Inventors: Guixue Yu, John Macor, Timothy Herpin, R. Lawrence, George Morton, Rejean Ruel, Graham Poindexter, Edward Ruediger, Carl Thibault
  • Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
    Publication number: 20050267119
    Abstract: The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
    Type: Application
    Filed: May 11, 2005
    Publication date: December 1, 2005
    Inventors: Hannguang Chao, Huji Tuerdi, Timothy Herpin, Jacques Roberge, Yalei Liu, R. Lawrence, Robert Rehfuss, Charles Clark, Jennifer Qiao, Timur Gungor, Patrick Lam, Tammy Wang, Rejean Ruel, Alexandre L'Heureux, Carl Thibeault, Gilles Bouthillier, Dora Schnur
  • Amino-benzazoles as P2Y1 receptor inhibitors
    Publication number: 20050203146
    Abstract: The present invention provides novel amino-benzazoles and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
    Type: Application
    Filed: January 19, 2005
    Publication date: September 15, 2005
    Inventors: Timothy Herpin, George Morton, Robert Rehfuss, R. Lawrence, Michael Poss, Jacques Roberge, Timur Gungor